209 related articles for article (PubMed ID: 31165776)
1. Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.
Cholankeril G; Li AA; Dennis BB; Gadiparthi C; Kim D; Toll AE; Maliakkal BJ; Satapathy SK; Nair S; Ahmed A
Sci Rep; 2019 Jun; 9(1):8312. PubMed ID: 31165776
[TBL] [Abstract][Full Text] [Related]
2. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
3. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
4. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
5. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
6. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
7. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
8. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
9. Impact of MELD-based allocation on end-stage renal disease after liver transplantation.
Sharma P; Schaubel DE; Guidinger MK; Goodrich NP; Ojo AO; Merion RM
Am J Transplant; 2011 Nov; 11(11):2372-8. PubMed ID: 21883908
[TBL] [Abstract][Full Text] [Related]
10. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
12. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
13. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
14. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
[TBL] [Abstract][Full Text] [Related]
15. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
16. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.
Sharpton SR; Feng S; Hameed B; Yao F; Lai JC
Transplantation; 2014 Sep; 98(5):557-62. PubMed ID: 24717221
[TBL] [Abstract][Full Text] [Related]
18. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]